RAPT Therapeutics (RAPT) Current Assets (2020 - 2024)
Historic Current Assets for Therapeutics (RAPT) over the last 5 years, with Q3 2024 value amounting to $102.6 million.
- Therapeutics' Current Assets fell 4517.52% to $102.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $102.6 million, marking a year-over-year decrease of 4517.52%. This contributed to the annual value of $161.8 million for FY2023, which is 3597.71% down from last year.
- Per Therapeutics' latest filing, its Current Assets stood at $102.6 million for Q3 2024, which was down 4517.52% from $120.5 million recorded in Q2 2024.
- Therapeutics' Current Assets' 5-year high stood at $252.7 million during Q4 2022, with a 5-year trough of $102.6 million in Q3 2024.
- For the 5-year period, Therapeutics' Current Assets averaged around $171.6 million, with its median value being $175.7 million (2022).
- As far as peak fluctuations go, Therapeutics' Current Assets surged by 7120.25% in 2022, and later plummeted by 4517.52% in 2024.
- Quarter analysis of 5 years shows Therapeutics' Current Assets stood at $115.6 million in 2020, then skyrocketed by 66.93% to $193.0 million in 2021, then skyrocketed by 30.95% to $252.7 million in 2022, then crashed by 35.98% to $161.8 million in 2023, then crashed by 36.58% to $102.6 million in 2024.
- Its Current Assets stands at $102.6 million for Q3 2024, versus $120.5 million for Q2 2024 and $148.4 million for Q1 2024.